Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Change in Young Mania Rating Scale (YMRS) total score from baseline to end of double-blind treatment
Changes from baseline to end of double-blind treatment in Brief Psychiatric Rating Scale (BPRS), Clinical Global Impression (CGI) severity, and Hamilton Depression Rating Scale (HAMD); incidence of adverse events throughout study.
18 Years to 65 Years (Adult)
November 15, 2005
January 24, 2011
† Study has passed its completion date and status has not been verified in more than two years.